Emami Limited

NSEI:EMAMILTD Stock Report

Market Cap: ₹281.3b

Emami Valuation

Is EMAMILTD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EMAMILTD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EMAMILTD (₹643.15) is trading above our estimate of fair value (₹301.72)

Significantly Below Fair Value: EMAMILTD is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EMAMILTD?

Key metric: As EMAMILTD is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for EMAMILTD. This is calculated by dividing EMAMILTD's market cap by their current earnings.
What is EMAMILTD's PE Ratio?
PE Ratio36.4x
Earnings₹7.73b
Market Cap₹281.26b

Price to Earnings Ratio vs Peers

How does EMAMILTD's PE Ratio compare to its peers?

The above table shows the PE ratio for EMAMILTD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average75.8x
507815 Gillette India
66.9xn/a₹302.6b
500459 Procter & Gamble Hygiene and Health Care
75.9x15.9%₹513.0b
500830 Colgate-Palmolive (India)
50.6x9.7%₹742.7b
HONASA Honasa Consumer
109.9x49.4%₹85.8b
EMAMILTD Emami
36.4x11.4%₹281.3b

Price-To-Earnings vs Peers: EMAMILTD is good value based on its Price-To-Earnings Ratio (36.4x) compared to the peer average (75.8x).

Price to Earnings Ratio vs Industry

How does EMAMILTD's PE Ratio compare vs other companies in the IN Personal Products Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
EMAMILTD 36.4xIndustry Avg. 25.1xNo. of Companies3PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: EMAMILTD is expensive based on its Price-To-Earnings Ratio (36.4x) compared to the Asian Personal Products industry average (25.1x).

Price to Earnings Ratio vs Fair Ratio

What is EMAMILTD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EMAMILTD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio36.4x
Fair PE Ratio43.9x

Price-To-Earnings vs Fair Ratio: EMAMILTD is good value based on its Price-To-Earnings Ratio (36.4x) compared to the estimated Fair Price-To-Earnings Ratio (43.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EMAMILTD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹643.15
₹801.12
+24.6%
14.9%₹980.00₹510.00n/a26
Nov ’25₹716.45
₹867.62
+21.1%
14.1%₹1,025.00₹510.00n/a26
Oct ’25₹753.65
₹867.81
+15.1%
14.1%₹1,025.00₹510.00n/a26
Sep ’25₹813.20
₹867.96
+6.7%
14.1%₹1,025.00₹510.00n/a26
Aug ’25₹824.10
₹755.40
-8.3%
18.3%₹1,025.00₹510.00n/a25
Jul ’25₹721.10
₹650.81
-9.7%
13.2%₹816.00₹510.00n/a26
Jun ’25₹625.50
₹617.59
-1.3%
7.7%₹735.00₹510.00n/a27
May ’25₹486.90
₹563.89
+15.8%
7.8%₹630.00₹470.00n/a27
Apr ’25₹439.85
₹572.59
+30.2%
7.4%₹650.00₹500.00n/a27
Mar ’25₹455.00
₹572.59
+25.8%
7.4%₹650.00₹500.00n/a27
Feb ’25₹498.60
₹593.08
+18.9%
9.2%₹690.00₹480.00n/a26
Jan ’25₹572.70
₹583.96
+2.0%
8.3%₹665.00₹480.00n/a26
Dec ’24₹515.80
₹582.00
+12.8%
8.2%₹665.00₹480.00n/a26
Nov ’24₹511.60
₹561.16
+9.7%
10.3%₹660.00₹450.00₹716.4525
Oct ’24₹538.45
₹547.63
+1.7%
10.2%₹660.00₹450.00₹753.6524
Sep ’24₹535.60
₹532.74
-0.5%
9.7%₹660.00₹450.00₹813.2023
Aug ’24₹462.25
₹480.96
+4.0%
8.8%₹590.00₹410.00₹824.1023
Jul ’24₹424.70
₹479.68
+12.9%
9.1%₹590.00₹410.00₹721.1022
Jun ’24₹387.35
₹482.52
+24.6%
9.7%₹590.00₹410.00₹625.5023
May ’24₹374.95
₹493.50
+31.6%
11.8%₹660.00₹410.00₹486.9022
Apr ’24₹358.55
₹501.19
+39.8%
11.2%₹660.00₹419.00₹439.8521
Mar ’24₹395.05
₹508.26
+28.7%
11.1%₹660.00₹419.00₹455.0023
Feb ’24₹428.60
₹549.61
+28.2%
8.7%₹660.00₹470.00₹498.6023
Jan ’24₹425.05
₹559.67
+31.7%
7.6%₹660.00₹470.00₹572.7024
Dec ’23₹463.55
₹559.67
+20.7%
7.6%₹660.00₹470.00₹515.8024
Nov ’23₹485.45
₹562.13
+15.8%
9.3%₹668.00₹470.00₹511.6024

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Dabur India

₹900.7b

Operates as a fast-moving consumer goods company worldwide.

500096

₹508.25

7D

-0.5%

1Y

-6.1%

Jyothy Labs

₹148.6b

Engages in the manufacture and marketing of fabric care, dishwashing, personal care, and household insecticides products in India and internationally.

JYOTHYLAB

₹404.75

7D

-8.3%

1Y

-9.7%

Godrej Consumer Products

₹1.2t

A fast-moving consumer goods company, engages in the manufacture and marketing of personal care and home care products in India, Africa, Indonesia, the Middle East, the United States of America, and internationally.

532424

₹1,185.90

7D

0.8%

1Y

18.5%